Brief: Glucotrack Inc Provides Development Update On Its Gen 2 Non-Invasive Glucose Monitor

GlucoTrack

22/06/2022 15:44

June 22 (Reuters) - GlucoTrack Inc  GCTK.O :
    * GLUCOTRACK, INC. PROVIDES DEVELOPMENT UPDATE ON ITS GEN 2
NON-INVASIVE GLUCOSE MONITOR
    * GLUCOTRACK INC - HAS RECENTLY RECEIVED ETHICS COMMITTEE
AND
CLINICAL CENTER APPROVALS TO CONDUCT STUDY AT RABIN MEDICAL
CENTER IN ISRAEL
    * GLUCOTRACK INC - INITIAL RESULTS FROM THIS STUDY WILL
DRIVE A
FOLLOW-UP MULTI-CENTER STUDY IN UNITED STATES
    * GLUCOTRACK INC - AIMS TO BEGIN ITS FIRST IN-HUMAN STUDY IN
ISRAEL IN Q3 AND IN U.S. CENTERS IN Q4

Source text for Eikon:  ID:nGNX5hDv7F 
Further company coverage:  GCTK.O 

 ((Reuters.Briefs@thomsonreuters.com;))